iRhythm Technologies to Present at the Morgan Stanley 15th Annual Global Healthcare Conference
iRhythm’s management is scheduled to present on
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
Investor Relations Contact:
Lynn Pieper Lewisor Leigh Salvo(415) 937-5404 firstname.lastname@example.org Media Contact Aaron Murphy(415) 229-3331 email@example.com